All In MedTech

Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

8

510(k) pathway

Device trials

11

Naming "Nautilus"

MAUDE reports

78

Brand "Nautilus", since 2015

PubMed studies

340

Mentioning "Nautilus"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Nautilus Spinal System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 8 decisions filed under this name.

3 more FDA decisions with a free account

Older decisions: K123373, K111953

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Nautilus", any status and sponsor, newest update first.

Open in Trial Radar
  • RNS System NAUTILUS StudyPivotal-lookingCompleted

    NeuroPaceNot on our public-company list

    NCT05147571 · 100 participants · Start Aug 9, 2022 · Primary completion Apr 4, 2025

    Device: Responsive stimulation; Sham stimulation · For: Epilepsy; Idiopathic Generalized Epilepsy; Generalized Tonic Clonic Seizure

    Sites: Birmingham, Alabama; Phoenix, Arizona; Aurora, Colorado · 23 sites in all

  • EndoStream MedicalNot on our public-company list

    NCT05550571 · 45 participants (planned) · Start Dec 17, 2022 · Primary completion Jul 1, 2026

    Device: Nautilus Intrasaccular Bridging System · For: Ruptured Cerebral Aneurysm

    Sites: Jacksonville, Florida; Tampa, Florida; Buffalo, New York · 5 sites in all

  • Jan Medical, Inc.Not on our public-company list

    NCT01643525 · 29 participants · Start Jun 2012 · Primary completion Dec 2012

    Device: Nautilus NeuroWaveTM System · For: Ischemic Stroke

    Sites: Baltimore, Maryland; Columbia, Maryland · 3 sites in all

8 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Nautilus", and for the whole product code for context.

This brand

78 reports: 53 malfunction, 19 injury, 5 death

Whole product code NKB

18,189 reports: 7,763 malfunction, 10,339 injury, 59 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recall in FDA's data is linked to these FDA numbers.

Published research

The most relevant PubMed records for "Nautilus"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code NKB.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.